Sarawak
Showing 1 - 25 of 234
Diabetes, Type 2 Trial in Kuching (Sago starch drink, Corn starch drink)
Recruiting
- Diabetes Mellitus, Type 2
- Sago starch drink
- Corn starch drink
-
Kuching, Sarawak, Malaysia
- +3 more
Jan 29, 2023
Pain, Postoperative, Anesthesia Trial in Kuching (Ultrasound-guided scalp block with ropivacaine 0.375%, Ultrasound-guided scalp
Not yet recruiting
- Pain, Postoperative
- Anesthesia
- Ultrasound-guided scalp block with ropivacaine 0.375%
- Ultrasound-guided scalp block with placebo
-
Kuching, Sarawak, MalaysiaSarawak General Hospital
Nov 7, 2023
Prolonged Cardiac ECG Patch Versus Conventional Holter For
Recruiting
- Stroke
- Atrial Fibrillation
-
Kuching, Sarawak, MalaysiaSarawak General Hospital
Oct 26, 2022
Left Atrial Appendage Occlusion With The Amplatzer Amulet
Recruiting
- Atrial Fibrillation
- Amplatzer Amulet Left Atrial Appendage Occlusion Device
-
Kuching, Sarawak, MalaysiaSarawak Heart Centre
Jan 26, 2023
Diabetes, Type2 Diabetes Trial in Malaysia (PICC Program, Control)
Recruiting
- Diabetes Mellitus
- Type2 Diabetes
- PICC Program
- Control
-
Daro, Sarawak, Malaysia
- +8 more
Dec 5, 2021
Transthoracic Ultrasound in Differentiating Tuberculous From
Recruiting
- Pleural Effusion
- +2 more
-
Kuching, Sarawak, MalaysiaSarawak General Hospital
Jun 28, 2023
Establishment of Aldosterone and Renin Reference Range
Recruiting
- Aldosteronism
-
Kuching, Sarawak, MalaysiaUniversiti Malaysia Sarawak
Jan 30, 2022
Palmar-Plantar Erythrodysesthesia, Palmar-Plantar Erythrodysesthesia Due to Cytotoxic Therapy Trial in Kuching (Moisturising
Recruiting
- Palmar-Plantar Erythrodysesthesia
- Palmar-Plantar Erythrodysesthesia Due to Cytotoxic Therapy
- Moisturising cream containing palm-oil derived vitamin E concentrate and urea cream
- +2 more
-
Kuching, Sarawak, MalaysiaSarawak General Hospital
Jul 2, 2023
Pneumonia Trial in Australia, Malaysia, New Zealand (Amoxicillin-clavulanic Acid, Placebo (for Amoxicillin-clavulanic Acid))
Active, not recruiting
- Pneumonia
- Amoxicillin-clavulanic Acid
- Placebo (for Amoxicillin-clavulanic Acid)
-
Darwin, Northern Territory, Australia
- +4 more
Apr 5, 2022
Advanced Solid Tumor Trial in Kuching (BL0020)
Not yet recruiting
- Advanced Solid Tumor
-
Kuching, MalaysiaSarawak General Hospital
May 24, 2023
InterVenn Ovarian CAncer Liquid Biopsy
Recruiting
- Adnexal Mass
- +2 more
-
Los Angeles, California
- +23 more
Jun 27, 2022
NSCLC Stage IIIB, NSCLC Stage IIIC, NSCLC Stage IV Trial in Worldwide (Dacomitinib)
Active, not recruiting
- NSCLC Stage IIIB
- +4 more
-
Hong Kong, Hong Kong
- +8 more
Jan 10, 2023
Heart Rate Variability on Endothelial Function Via RAAS
Not yet recruiting
- Obstructive Sleep Apnea
-
Kuching, Sarawak, MalaysiaUniversiti Malaysia Sarawak
Jan 30, 2022
Malay Version of painDETECT Questionnaire
Completed
- Neuropathic Pain, Nociceptive Pain
- Questionnaire
-
Pulau Pinang, Penang, Malaysia
- +3 more
Jan 6, 2023
NSCLC Trial in Korea, Republic of, Malaysia, United States (Cetrelimab, Amivantamab)
Recruiting
- Carcinoma, Non-Small-Cell Lung
-
Fairfax, Virginia
- +3 more
Jun 16, 2023
Stroke, Atrial Fibrillation Trial in Kuching (Smartphone ECG)
Completed
- Stroke
- Atrial Fibrillation
- Smartphone ECG
-
Kuching, Sarawak, MalaysiaSarawakHC
May 4, 2022
Asian Multicenter Prospective Study of ctDNA Sequencing
Recruiting
- Cervical Cancer
- +5 more
- NGS analysis of ctDNA
-
Tokyo, Japan
- +18 more
Sep 28, 2022
COVID-19 Pandemic Trial in Malaysia, Pakistan (Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01), Blank Preparation of
Active, not recruiting
- COVID-19 Pandemic
- Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01)
- Blank Preparation of Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01)
-
Kuching, Sarawak, Malaysia
- +17 more
Aug 31, 2022
Head and Neck Squamous Cell Carcinoma (HNSCC) Trial in Worldwide (BI 765063, Ezabenlimab, BI 836880)
Recruiting
- Head and Neck Squamous Cell Carcinoma (HNSCC)
- BI 765063
- +4 more
-
Saint Louis, Missouri
- +15 more
Aug 10, 2022
Nasopharyngeal Carcinoma, EBV-Related Gastric Carcinoma, EBV-Related Leiomyosarcoma Trial in Worldwide (Nanatinostat,
Recruiting
- Nasopharyngeal Carcinoma
- +4 more
- Nanatinostat
- +2 more
-
Lynwood, California
- +20 more
Jul 27, 2022
Dengue Fever, Dengue Hemorrhagic Fever Trial in Malaysia (Live, attenuated, recombinant dengue serotypes 1, 2, 3, and 4 virus,
Completed
- Dengue Fever
- Dengue Hemorrhagic Fever
- Live, attenuated, recombinant dengue serotypes 1, 2, 3, and 4 virus
- Placebo: NaCl 0.9%
-
Ipoh, Perak, Malaysia
- +3 more
Mar 15, 2022
Non-transfusion-dependent Thalassemia, Low Risk Myelodysplastic Syndrome, Very-Low Risk Myelodysplastic Syndrome Trial in
Recruiting
- Non-transfusion-dependent Thalassemia
- +2 more
- SLN124
- Placebo
-
Düsseldorf, Germany
- +19 more
Mar 18, 2022
COVID-19 Trial in Malaysia (Ivermectin 0.4mg/kg/day for 5 days)
Completed
- COVID-19
- Ivermectin 0.4mg/kg/day for 5 days
-
Johor Bahru, Johor, Malaysia
- +20 more
Nov 24, 2021
Influenza, Human Trial in Worldwide (QIVc, Comparator)
Active, not recruiting
- Influenza, Human
- QIVc
- Comparator
-
Dobrich, Bulgaria
- +54 more
Jan 17, 2023